Stroke Sample Clauses

Stroke. A cerebrovascular incident including infarction of brain tissue, cerebral and subarachnoid haemorrhage, intracerebral embolism and cerebral thrombosis resulting in permanent neurological deficit with persisting clinical symptoms. This diagnosis must be supported by all of the following conditions:
Stroke. A cerebrovascular incident including infarction of brain tissue, cerebral and subarachnoid haemorrhage, intracerebral embolism and cerebral thrombosis resulting in permanent neurological deficit with persisting clinical symptoms. This diagnosis must be supported by all of the following conditions: • Evidence of permanent clinical neurological deficit confirmed by a neurologist at least 6 weeks after the event; and • Findings on Magnetic Resonance Imaging, Computerised Tomography, or other reliable imaging techniques consistent with the diagnosis of a new stroke. The following are excluded: • Transient Ischaemic Attacks; • Brain damage due to an accident or injury, infection, vasculitis, and inflammatory disease; • Vascular disease affecting the eye or optic nerve; and • Ischaemic disorders of the vestibular system.
Stroke. A transient ischemic attack (TIA) is caused by the changes in the blood supply to a particular area of the brain; resulting in brief neurologic dysfunction that persists, by definition, for less than 24 hours; if symptoms persist then it is categorized as a stroke. There were about as much as 900,000 strokes or transient ischemic attacks in the United States every year [2]. Atherosclerotic stenosis of the major intracranial arteries was believed to be one of the most important causes of transient ischemic attack (TIA) or stroke, and it could cause about 8 – 10% of the strokes or transient ischemic attacks every year in the United States [3, 4]. Moreover, the risk of recurrent stroke of these patients, which had the history of atherosclerotic stenosis of the major intracranial arteries, can be as high as 15% per year [5-9]. To lower the risk of stroke, several anti-clotting agents were used. Among these, aspirin's efficacy as an anti-clotting agent was proved by some studies from the 1960s to the 1980s. Hence, it was widespread used as a preventive treatment for heart attacks and strokes from the last decades of the twentieth century. In addition to aspirin, another anticoagulant, warfarin, which was initially marketed as a pesticide against rats and mice, was also frequently used for the treatment of intracranial stenosis based on the results of several retrospective studies, some of which suggested that warfarin may be more effective than aspirin [6, 7, 10, 11]. Both aspirin and warfarin were usually used for the treatment of intracranial stenosis, but it was still not clear which strategy is better. A recent survey illustrated uncertainty about optimal antithrombotic therapy for intracranial arterial stenosis. It showed that the number of neurologists who prefer warfarin therapy for this disease was similar with that of those who prefer aspirin therapy in the United States [12]. Given the importance of intracranial stenosis and lack of studies to compare treatments [13], a clinical trial was conducted to compare the effects between aspirin and warfarin in patients with this disease [14].
Stroke. Any cerebrovascular incident including infarction of brain tissue, thrombosis in an intracranial vessel, hemorrhage and embolisation from an extra cranial source, which results in neurological sequelae. Transient Ischemic Attacks (TIA) are excluded. Treatment of the neurological sequelae is excluded from the cover if the primary condition is not covered.
Stroke. Cerebrovascular accident caused by infarction of brain tissue, hemorrhage or embolism, producing measurable neurological deficit persisting for at least 30 days following the occurrence of the stroke. Conditions NOT covered by this definition include, but are not limited to, transient ischemic attack (TIA). Policy Conditions: 1. WAITING PERIOD - Coverage commences 30 days after the Policy Issue Date (or the Policy Reinstatement Date, if applicable). The Waiting Period would be waived if a covered impairment was caused by an accident which occurred while the policy was in force.
Stroke. The incidence of stroke during the index hospitalization will be analyzed for all safety evaluable subjects and the ITT population using the chi-square as specified above in Statistics Section. Stroke will be adjudicated using the following criteria: a new the rapid onset of new neurological deficit of cerebrovascular cause that persists beyond 24 hours (non-fatal) or is interrupted by death within 24 hours (any) with evidence of new neurological lesion on imaging modalities.
Stroke 

Related to Stroke

  • Nepotism No person shall be employed or contracted with if a member of his or her immediate family is on the Board of Directors of the Subrecipient or is employed in an administrative capacity by the Subrecipient. For the purposes of this section, “immediate family” includes: wife, husband, daughter, son, mother, father, brother, sister, brother-in-law, sister-in-law, father-in-law, mother-in- law, aunt, uncle, niece, nephew, stepparent and stepchild; “administrative capacity” includes those who have selection, hiring, supervisory or operational responsibility for the program.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Safety Glasses Section 1. The City shall supply prescription safety glasses with plastic lenses to employees who are required to wear safety glasses and who are members of the classifications contained in Appendix C to this contract. Safety glasses which are authorized must be industrial grade safety glasses which meet or exceed the requirements of ANSI Specification Z87.1. All employees who are required to wear safety glasses shall also be required to wear side xxxxxxx, either permanent or snap-on, whenever an eye hazard exists. Solid tinted glasses will not be approved unless required by prescription. Photogray, progressive, scratch coating and/or anti-glare lenses may be considered for those employees who primarily work outdoors or as prescribed. In the event that additional classes are identified as needing either prescription safety glasses or protective eyewear, such classes may be added to the classification list in Appendix C upon approval of PAGE and the City.

  • Communicable Diseases Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak.

  • Workplace Violence (a) It is recognized that at certain worksites or in certain work situations employees may be at risk of physical violence or verbal abuse from clients, persons in care or custody, or the public.